Page 81 - புனே அடிப்படையிலானது சீரம் நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Serum Institute likely to seek permission for selling Covishield commercially: Report

SII may apply to Central Drugs Standard Control Organisation. New Delhi: Pune-based Serum Institute of India (SII), that is manufacturing COVID-19 vaccine, may apply for ‘marketing authorisation’ for Covishield, as per a business daily report. If granted permission, SII will be able to to sell the vaccine commercially. Serum Institute might seek permission for selling Covishield commercially from the Central Drugs Standard Control Organisation (CDSCO) by the end of April, Business Standard reported. Covishield is developed by British Swedish drugmaker AstraZeneca and the University of Oxford. India has approved two vaccines against COVID-19 Covishield, manufactured by the SII, and the indigenously-developed Covaxin of Bharat Biotech for restricted emergency use in the country.

Uttar pradeshUnited kingdomNew delhiUniversity of oxfordSerum instituteSerum institute of indiaHealth ministryCentral drugs standard control organisationPune based serum instituteBusiness standardBritish swedishWest bengalCovid 19Corona virusSerum institute of india vaccineSerum institute of india covid vaccine sale

Covid19 Third Phase Vaccination, Covid19 vaccine registration, Cowin app for registration, Cowin app for third phase

Covid19 Third Phase Vaccination, Covid19 vaccine registration, Cowin app for registration, Cowin app for third phase
indiatvnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatvnews.com Daily Mail and Mail on Sunday newspapers.

Harsh vardhanUnion healthBharat biotech internationalSerum institute of indiaImage sourceHealth secretaryr bhushanWhile covishieldPune based serum instituteHyderabad based bharat biotech internationalHealth minister harsh vardhanகடுமையான வர்தன்தொழிற்சங்கம் ஆரோக்கியம்பாரத் பயோடெக் சர்வதேசசீரம் நிறுவனம் ஆஃப் இந்தியாபடம் மூலபுனே அடிப்படையிலானது சீரம் நிறுவனம்

Drug regulator extends Covishield s shelf life from 6 to 9 months

Drug regulator extends Covishield s shelf life from 6 to 9 months
businesstoday.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businesstoday.in Daily Mail and Mail on Sunday newspapers.

United kingdomSerum institute of indiaOxford universityWorld health organisationDrug controller generalPune based serum instituteController generalSouth korean made astrazenecaஒன்றுபட்டது கிஂக்டம்சீரம் நிறுவனம் ஆஃப் இந்தியாஆக்ஸ்ஃபர்ட் பல்கலைக்கழகம்உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந்மருந்து கட்டுப்படுத்தி ஜநரல்புனே அடிப்படையிலானது சீரம் நிறுவனம்கட்டுப்படுத்தி ஜநரல்

Hope to launch Covovax by September this year, says Adar Poonawalla

Hope to launch Covovax by September this year, says Adar Poonawalla
aninews.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aninews.in Daily Mail and Mail on Sunday newspapers.

United kingdomNew delhiOxford universitySerum institute of indiaPune based serum instituteSerum instituteஒன்றுபட்டது கிஂக்டம்புதியது டெல்ஹிஆக்ஸ்ஃபர்ட் பல்கலைக்கழகம்சீரம் நிறுவனம் ஆஃப் இந்தியாபுனே அடிப்படையிலானது சீரம் நிறுவனம்சீரம் நிறுவனம்

Hope Covovax to launch by Sep: Poonawalla

Hope Covovax to launch by Sep: Poonawalla
theuknews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theuknews.com Daily Mail and Mail on Sunday newspapers.